Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet.
Lagadinou ED, Marangos M, Liga M, Panos G, Tzouvara E, Dimitroulia E, Tiniakou M, Tsakris A, Zoumbos N, Spyridonidis A. Lagadinou ED, et al. Among authors: liga m. Transpl Infect Dis. 2010 Oct;12(5):437-40. doi: 10.1111/j.1399-3062.2010.00515.x. Transpl Infect Dis. 2010. PMID: 20561301
High alloreactivity of low-dose prophylactic donor lymphocyte infusion in patients with acute leukemia undergoing allogeneic hematopoietic cell transplantation with an alemtuzumab-containing conditioning regimen.
Liga M, Triantafyllou E, Tiniakou M, Lambropoulou P, Karakantza M, Zoumbos NC, Spyridonidis A. Liga M, et al. Biol Blood Marrow Transplant. 2013 Jan;19(1):75-81. doi: 10.1016/j.bbmt.2012.07.021. Epub 2012 Aug 4. Biol Blood Marrow Transplant. 2013. PMID: 22871557 Free article. Clinical Trial.
A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation.
Sakellari I, Angelopoulou M, Tsopra O, Dervenoulas I, Tsirigotis P, Spyridonidis A, Liga M, Tsionos K, Anargyrou K, Pouli A, Anagnostopoulos A. Sakellari I, et al. Among authors: liga m. Ann Hematol. 2015 Oct;94(10):1733-40. doi: 10.1007/s00277-015-2437-5. Epub 2015 Jul 5. Ann Hematol. 2015. PMID: 26141369
Pretransplant Genetic Susceptibility: Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy.
Gavriilaki E, Touloumenidou T, Sakellari I, Batsis I, Mallouri D, Psomopoulos F, Tsagiopoulou M, Koutra M, Yannaki E, Papalexandri A, Taylor P, Nikolousis E, Stamouli M, Holbro A, Baltadakis I, Liga M, Spyridonidis A, Tsirigotis P, Charchalakis N, Tsakiris DA, Brodsky RA, Passweg J, Stamatopoulos K, Anagnostopoulos A. Gavriilaki E, et al. Among authors: liga m. Thromb Haemost. 2020 Apr;120(4):638-646. doi: 10.1055/s-0040-1702225. Epub 2020 Mar 4. Thromb Haemost. 2020. PMID: 32131130
Tongue graft-versus-host disease: remission with ruxolitinib.
Grafanaki K, Lygeros S, Spyridonidis A, Liga M. Grafanaki K, et al. Among authors: liga m. BMJ Case Rep. 2022 May 23;15(5):e247888. doi: 10.1136/bcr-2021-247888. BMJ Case Rep. 2022. PMID: 35606043 Free PMC article.
20 results